Dual antiplatelet therapy in acute coronary syndrome: the role of prasugrel
This review discusses the results of randomized controlled trials TRITON-TIMI 38, TRILOGY ACS, and ACCOAST, which have informed our current views on the place of prasugrel in treatment of acute coronary syndrome. It also provides excerpts from current clinical guidelines for treatment of acute coronary syndrome that touch on the use of prasugrel.